Nucleic acid affinity columns
First Claim
1. A method for eliminating a plurality of preselected gene products from a nucleic acid sample comprising:
- providing an affinity matrix comprising at least one nucleic acid affinity ligand complementary to each of the plurality of preselected gene products;
hybridizing the nucleic acid sample to the affinity matrix; and
eluting the sample from the affinity matrix;
thereby substantially depleting the nucleic acid sample of the preselected gene products.
4 Assignments
0 Petitions
Accused Products
Abstract
This invention provides nucleic acid affinity matrices that bear a large number of different nucleic acid affinity ligands allowing the simultaneous selection and removal of a large number of preselected nucleic acids from the sample. Methods of producing such affinity matrices are also provided. In general the methods involve the steps of a) providing a nucleic acid amplification template array comprising a surface to which are attached at least 50 oligonucleotides having different nucleic acid sequences, and wherein each different oligonucleotide is localized in a predetermined region of said surface, the density of said oligonucleotides is greater than about 60 different oligonucleotides per 1 cm2, and all of said different oligonucleotides have an identical terminal 3′ nucleic acid sequence and an identical terminal 5′ nucleic acid sequence. b) amplifying said multiplicity of oligonucleotides to provide a pool of amplified nucleic acids; and c) attaching the pool of nucleic acids to a solid support.
-
Citations
7 Claims
-
1. A method for eliminating a plurality of preselected gene products from a nucleic acid sample comprising:
-
providing an affinity matrix comprising at least one nucleic acid affinity ligand complementary to each of the plurality of preselected gene products;
hybridizing the nucleic acid sample to the affinity matrix; and
eluting the sample from the affinity matrix;
thereby substantially depleting the nucleic acid sample of the preselected gene products.- View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification